Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

ARHGAP32 ARHGAP36 ARHGAP10 MON1A GMIP DENND2B FARP2 CCDC88A RASA4 FARP1 KIAA1755 RASA4B PLCG1 ARHGAP27

5.23e-0650712914GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

ARHGAP32 ARHGAP36 ARHGAP10 MON1A GMIP DENND2B FARP2 CCDC88A RASA4 FARP1 KIAA1755 RASA4B PLCG1 ARHGAP27

5.23e-0650712914GO:0030695
GeneOntologyMolecularFunctionenzyme regulator activity

ARHGAP32 CPAMD8 ARHGAP36 ARHGAP10 INS MON1A GMIP WNK1 DENND2B FARP2 CCDC88A RASA4 FARP1 KIAA1755 RASA4B PRKD1 PLCG1 GNAS ARHGAP27 INS-IGF2 CBX8 PTTG2 PHACTR1

3.61e-05141812923GO:0030234
GeneOntologyMolecularFunctioninsulin receptor binding

INS CCDC88A PLCG1 INS-IGF2

4.00e-05301294GO:0005158
GeneOntologyMolecularFunctioninsulin-like growth factor receptor binding

INS GNAS INS-IGF2

2.00e-04181293GO:0005159
GeneOntologyMolecularFunctionenzyme activator activity

ARHGAP32 ARHGAP36 ARHGAP10 INS GMIP WNK1 CCDC88A RASA4 RASA4B GNAS ARHGAP27 INS-IGF2 CBX8

3.30e-0465612913GO:0008047
GeneOntologyBiologicalProcesspositive regulation of cell differentiation

MAG ARHGAP32 NKX6-2 INS LAMC1 CAMK1 DICER1 SHANK3 BTN2A1 ADM BTN2A2 FBN2 PLXNC1 BTN2A3P SMARCA4 ROBO1 NID1 PRKD1 PRKDC GNAS IL2RG TNXB IL33

7.80e-07114113123GO:0045597
GeneOntologyBiologicalProcesspositive regulation of cell development

MAG ARHGAP32 NKX6-2 DICER1 SHANK3 BTN2A1 BTN2A2 PLXNC1 BTN2A3P SMARCA4 ROBO1 PRKDC GNAS IL2RG IL33

8.50e-0661413115GO:0010720
GeneOntologyBiologicalProcessregulation of regulatory T cell differentiation

DICER1 BTN2A1 BTN2A2 BTN2A3P IL2RG

1.46e-05491315GO:0045589
GeneOntologyBiologicalProcessneuron development

MAG SEMA4F ARHGAP32 CPNE9 HECW1 INS DVL2 LAMC1 LAMC3 CAMK1 WNK1 DICER1 SHANK3 FARP2 ADM CCDC88A PLXNC1 FARP1 KIAA1755 ROBO1 PRKD1 TNXB TOP2B PHACTR1

1.52e-05146313124GO:0048666
GeneOntologyBiologicalProcessneuron projection development

MAG SEMA4F ARHGAP32 CPNE9 HECW1 INS DVL2 LAMC1 LAMC3 CAMK1 DICER1 SHANK3 ADM CCDC88A PLXNC1 FARP1 KIAA1755 ROBO1 PRKD1 TNXB TOP2B PHACTR1

1.90e-05128513122GO:0031175
GeneOntologyBiologicalProcesspositive regulation of vascular endothelial growth factor signaling pathway

JCAD ROBO1 TNXB

2.05e-0591313GO:1900748
GeneOntologyBiologicalProcesscellular response to calcium ion

CPNE9 MYLK WNK1 RASA4 RASA4B PLCG2

2.07e-05881316GO:0071277
GeneOntologyBiologicalProcessregulatory T cell differentiation

DICER1 BTN2A1 BTN2A2 BTN2A3P IL2RG

2.36e-05541315GO:0045066
GeneOntologyBiologicalProcessmuscle cell differentiation

SORBS2 INS MYOM3 LAMC1 CAMK1 DICER1 CHRNB1 ADM ADRA1A SMARCA4 NID1 PRKD1 INS-IGF2

3.43e-0553113113GO:0042692
GeneOntologyBiologicalProcesspositive regulation of regulatory T cell differentiation

BTN2A1 BTN2A2 BTN2A3P IL2RG

4.28e-05311314GO:0045591
GeneOntologyBiologicalProcessneuron projection morphogenesis

MAG SEMA4F ARHGAP32 CPNE9 HECW1 DVL2 LAMC1 LAMC3 DICER1 SHANK3 PLXNC1 FARP1 KIAA1755 ROBO1 TOP2B PHACTR1

5.01e-0580213116GO:0048812
GeneOntologyBiologicalProcessregulation of cell development

MAG SEMA4F ARHGAP32 NKX6-2 INS DICER1 SHANK3 BTN2A1 BTN2A2 PLXNC1 BTN2A3P SMARCA4 ROBO1 PRKDC GNAS KAT6B IL2RG IL33 INS-IGF2

6.29e-05109513119GO:0060284
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

MAG SEMA4F ARHGAP32 CPNE9 HECW1 DVL2 LAMC1 LAMC3 DICER1 SHANK3 PLXNC1 FARP1 KIAA1755 ROBO1 TOP2B PHACTR1

6.42e-0581913116GO:0120039
GeneOntologyBiologicalProcesscell morphogenesis

MAG SEMA4F ARHGAP32 CPNE9 HECW1 MYO10 DVL2 LAMC1 LAMC3 DICER1 SHANK3 PLXNC1 FARP1 CGN SMARCA4 KIAA1755 ROBO1 PRKDC TOP2B PHACTR1

6.45e-05119413120GO:0000902
GeneOntologyBiologicalProcesscell projection morphogenesis

MAG SEMA4F ARHGAP32 CPNE9 HECW1 DVL2 LAMC1 LAMC3 DICER1 SHANK3 PLXNC1 FARP1 KIAA1755 ROBO1 TOP2B PHACTR1

7.10e-0582613116GO:0048858
GeneOntologyBiologicalProcessresponse to calcium ion

CPNE9 MYLK WNK1 SLC25A12 RASA4 RASA4B PLCG2

7.69e-051611317GO:0051592
GeneOntologyBiologicalProcesssphinganine metabolic process

SPTLC1 DEGS2

1.20e-0431312GO:0006667
GeneOntologyBiologicalProcessnegative regulation of NAD(P)H oxidase activity

INS INS-IGF2

1.20e-0431312GO:0033861
GeneOntologyBiologicalProcesssmall GTPase-mediated signal transduction

RAB9B ARHGAP32 ARHGAP10 GMIP FARP2 ADRA1A CCDC88A RASA4 FARP1 ROBO1 RASA4B ARHGAP27

1.67e-0453813112GO:0007264
GeneOntologyBiologicalProcessregulation of anatomical structure morphogenesis

MAG JCAD SEMA4F ARHGAP32 CPNE9 HECW1 MYO10 DVL2 WNK1 DICER1 SHANK3 ADM TJP1 PLXNC1 ROBO1 PRKD1 PLCG1 PRKDC

1.85e-04109013118GO:0022603
GeneOntologyBiologicalProcesspositive regulation of nitric oxide mediated signal transduction

INS INS-IGF2

2.38e-0441312GO:0010750
GeneOntologyBiologicalProcesspositive regulation of synapse structural plasticity

CAMK1 SHANK3

2.38e-0441312GO:0051835
GeneOntologyBiologicalProcessnegative regulation of glycogen catabolic process

INS INS-IGF2

2.38e-0441312GO:0045818
GeneOntologyBiologicalProcessnegative regulation of activated T cell proliferation

BTN2A1 BTN2A2 BTN2A3P

2.64e-04201313GO:0046007
GeneOntologyBiologicalProcessMAPK cascade

JCAD INS DUSP8 DVL2 GRM4 DENND2B SHANK3 BTN2A1 BTN2A2 ADRA1A NRK BTN2A3P ROBO1 PLCG2 INS-IGF2 MAP3K2

2.75e-0493013116GO:0000165
GeneOntologyBiologicalProcessmuscle structure development

SORBS2 MYLK INS MYOM3 LAMC1 CAMK1 DICER1 CHRNB1 ADM ADRA1A XIRP2 SMARCA4 NID1 PRKD1 INS-IGF2

3.65e-0485813115GO:0061061
GeneOntologyBiologicalProcesshair follicle cell proliferation

LAMC1 DICER1

3.95e-0451312GO:0071335
GeneOntologyBiologicalProcesspositive regulation of lipid kinase activity

INS INS-IGF2

3.95e-0451312GO:0090218
GeneOntologyBiologicalProcessregulation of integrin-mediated signaling pathway

LAMC1 NID1 PRKD1

4.04e-04231313GO:2001044
GeneOntologyBiologicalProcessnegative regulation of G1/S transition of mitotic cell cycle

BTN2A1 BTN2A2 BTN2A3P SLFN11 PRKDC

4.05e-04981315GO:2000134
GeneOntologyBiologicalProcesspostsynaptic membrane organization

SORBS2 SHANK3 CHRNB1 FARP1

4.42e-04561314GO:0001941
GeneOntologyCellularComponentCOPI-coated Golgi to ER transport vesicle

CCDC88A GNAS

3.78e-0521292GO:0030142
GeneOntologyCellularComponentprotein complex involved in cell-matrix adhesion

LAMC1 NID1 TNXB

1.47e-04171293GO:0098637
GeneOntologyCellularComponentcell leading edge

MPP2 JCAD SORBS2 MYLK MYO10 CCDC88A DPP9 ROBO1 PLCG1 PLCG2 GNAS

2.76e-0450012911GO:0031252
MousePhenoincreased response to antigen

BTN2A1 BTN2A2 BTN2A3P

7.87e-0661043MP:0020002
MousePhenoabnormal habituation

ARHGAP32 SHANK3 CCDC88A IL33

2.74e-05241044MP:0011617
MousePhenoabnormal nonassociative learning

ARHGAP32 SHANK3 CCDC88A IL33

4.45e-05271044MP:0011616
MousePhenodecreased spinal cord ventral horn cell number

MORC2 DYNC1H1

5.48e-0521042MP:0005113
MousePhenoincreased IgG2c level

BTN2A1 BTN2A2 BTN2A3P

6.32e-05111043MP:0008896
DomainRho_GTPase_activation_prot

ARHGAP32 ARHGAP36 ARHGAP10 GMIP PLXNC1 RASA4 RASA4B ARHGAP27

1.59e-07881288IPR008936
DomainPH

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

4.05e-0622912810PF00169
Domain-

CPNE9 HECW1 RASA4 PLA2G4B RASA4B PLCG1 PLCG2 SNRNP200

8.25e-0614812882.60.40.150
DomainC2_dom

CPNE9 HECW1 RASA4 PLA2G4B RASA4B PLCG1 PLCG2 SNRNP200

1.74e-051641288IPR000008
DomainSH3

MPP2 ARHGAP32 SORBS2 ARHGAP10 SHANK3 TJP1 PLCG1 PLCG2 ARHGAP27

1.82e-052161289SM00326
DomainSH3

MPP2 ARHGAP32 SORBS2 ARHGAP10 SHANK3 TJP1 PLCG1 PLCG2 ARHGAP27

1.82e-052161289PS50002
DomainSH3_domain

MPP2 ARHGAP32 SORBS2 ARHGAP10 SHANK3 TJP1 PLCG1 PLCG2 ARHGAP27

2.10e-052201289IPR001452
DomainPH

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

2.20e-0527812810SM00233
DomainPH_DOMAIN

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

2.27e-0527912810PS50003
DomainPH_domain

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

2.34e-0528012810IPR001849
DomainC2

CPNE9 HECW1 RASA4 PLA2G4B RASA4B PLCG1 PLCG2

3.32e-051311287PF00168
DomainC2

CPNE9 HECW1 RASA4 PLA2G4B RASA4B PLCG1 PLCG2

4.43e-051371287SM00239
DomainPLC-gamma

PLCG1 PLCG2

4.66e-0521282IPR016279
DomainC2

CPNE9 HECW1 RASA4 PLA2G4B RASA4B PLCG1 PLCG2

5.56e-051421287PS50004
DomainRhoGAP

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

6.62e-05621285SM00324
DomainRhoGAP

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

7.15e-05631285PF00620
DomainRhoGAP_dom

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

7.71e-05641285IPR000198
DomainRHOGAP

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

7.71e-05641285PS50238
Domain-

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

7.71e-056412851.10.555.10
Domain-

RASA4 RASA4B

1.39e-04312824.10.1130.10
Domain-

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

3.65e-04391128102.30.29.30
Domain-

DPP8 DPP9

6.87e-04612822.140.10.30
DomainDPPIV_N

DPP8 DPP9

6.87e-0461282PF00930
DomainPeptidase_S9B_N

DPP8 DPP9

6.87e-0461282IPR002469
DomainPH_dom-like

ARHGAP10 MYO10 FARP2 RASA4 FARP1 RASA4B PRKD1 PLCG1 PLCG2 ARHGAP27

7.11e-0442612810IPR011993
Domainfn3

IGFN1 MYLK MYOM3 ROBO1 IL2RG TNXB

8.81e-041621286PF00041
DomainLAMININ_IVA

LAMC1 LAMC3

1.27e-0381282PS51115
DomainLaminin_B

LAMC1 LAMC3

1.27e-0381282PF00052
DomainLamB

LAMC1 LAMC3

1.27e-0381282SM00281
DomainLaminin_IV

LAMC1 LAMC3

1.27e-0381282IPR000034
DomainRNaseH-like_dom

ZNF862 ISG20 EXD3 AGO3

1.29e-03691284IPR012337
DomainBTK

RASA4 RASA4B

1.63e-0391282SM00107
DomainPAZ

DICER1 AGO3

1.63e-0391282PS50821
DomainPAZ

DICER1 AGO3

1.63e-0391282SM00949
DomainPAZ

DICER1 AGO3

1.63e-0391282PF02170
DomainZnf_Btk_motif

RASA4 RASA4B

1.63e-0391282IPR001562
DomainBTK

RASA4 RASA4B

1.63e-0391282PF00779
DomainZF_BTK

RASA4 RASA4B

1.63e-0391282PS51113
Domain-

INS INS-IGF2

1.63e-03912821.10.100.10
DomainPAZ_dom

DICER1 AGO3

1.63e-0391282IPR003100
DomainFN3

IGFN1 MYLK MYOM3 ROBO1 IL2RG TNXB

1.74e-031851286SM00060
DomainIGv

BTN2A1 BTN2A2 BTN2A3P ROBO1

1.76e-03751284SM00406
DomainIg_I-set

MAG IGFN1 MYLK MYOM3 HEPACAM2 ROBO1

1.99e-031901286IPR013098
DomainI-set

MAG IGFN1 MYLK MYOM3 HEPACAM2 ROBO1

1.99e-031901286PF07679
DomainInsulin

INS INS-IGF2

2.02e-03101282PF00049
DomainP-loop_NTPase

MPP2 RAB9B MYO10 GAL3ST4 DICER1 TJP1 YLPM1 SMARCA4 ABCC12 SLFN11 GNAS SNRNP200 RAB27A DYNC1H1

2.03e-0384812814IPR027417
DomainInsulin

INS INS-IGF2

2.46e-03111282IPR004825
DomainPeptidase_S9

DPP8 DPP9

2.46e-03111282PF00326
DomainInsulin-like

INS INS-IGF2

2.46e-03111282IPR016179
DomainIlGF

INS INS-IGF2

2.46e-03111282SM00078
DomainPeptidase_S9

DPP8 DPP9

2.46e-03111282IPR001375
DomainFN3

IGFN1 MYLK MYOM3 ROBO1 IL2RG TNXB

2.51e-031991286PS50853
DomainIg_V-set

MAG HEPACAM2 BTN2A1 BTN2A2 BTN2A3P ROBO1

2.51e-031991286IPR013106
DomainC2-set_2

MAG BTN2A1 BTN2A2

2.77e-03411283PF08205
DomainCD80_C2-set

MAG BTN2A1 BTN2A2

2.77e-03411283IPR013162
DomainSH3_2

MPP2 SORBS2 SHANK3 TJP1

2.90e-03861284PF07653
DomainSH3_2

MPP2 SORBS2 SHANK3 TJP1

2.90e-03861284IPR011511
DomainFN3_dom

IGFN1 MYLK MYOM3 ROBO1 IL2RG TNXB

3.20e-032091286IPR003961
DomainIg-like_fold

MAG IGFN1 MYLK MYOM3 HEPACAM2 BTN2A1 BTN2A2 PLXNC1 BTN2A3P ROBO1 IL2RG TNXB

3.37e-0370612812IPR013783
DomainFA

FARP2 FARP1

3.46e-03131282PF08736
DomainFERM-adjacent

FARP2 FARP1

3.46e-03131282IPR014847
DomainFA

FARP2 FARP1

3.46e-03131282SM01195
DomainFERM_M

MYO10 FARP2 FARP1

3.85e-03461283PF00373
DomainRasGAP

RASA4 RASA4B

4.02e-03141282SM00323
DomainRasGAP_CS

RASA4 RASA4B

4.02e-03141282IPR023152
Domain-

ISG20 EXD3 AGO3

4.09e-034712833.30.420.10
DomainPRY

BTN2A1 BTN2A2 BTN2A3P

4.34e-03481283SM00589
DomainPRY

BTN2A1 BTN2A2 BTN2A3P

4.34e-03481283IPR006574
DomainGrowth_fac_rcpt_

LAMC1 LAMC3 FBN2 NID1 TNXB

4.43e-031561285IPR009030
Domain-

MYO10 FARP2 FARP1

4.60e-034912831.20.80.10
DomainFERM_central

MYO10 FARP2 FARP1

4.60e-03491283IPR019748
DomainFERM_domain

MYO10 FARP2 FARP1

4.60e-03491283IPR000299
DomainRasGAP

RASA4 RASA4B

4.62e-03151282PF00616
DomainEF-hand_like

PLCG1 PLCG2

4.62e-03151282PF09279
DomainRAS_GTPASE_ACTIV_1

RASA4 RASA4B

4.62e-03151282PS00509
DomainPI-PLC-Y

PLCG1 PLCG2

4.62e-03151282PF00387
DomainPLCYc

PLCG1 PLCG2

4.62e-03151282SM00149
DomainPLipase_C_Pinositol-sp_Y

PLCG1 PLCG2

4.62e-03151282IPR001711
DomainPIPLC_Y_DOMAIN

PLCG1 PLCG2

4.62e-03151282PS50008
DomainRAS_GTPASE_ACTIV_2

RASA4 RASA4B

4.62e-03151282PS50018
DomainPI-PLC_fam

PLCG1 PLCG2

4.62e-03151282IPR001192
DomainPLC_EF-hand-like

PLCG1 PLCG2

4.62e-03151282IPR015359
DomainFERM/acyl-CoA-bd_prot_3-hlx

MYO10 FARP2 FARP1

4.87e-03501283IPR014352
DomainFERM_1

MYO10 FARP2 FARP1

4.87e-03501283PS00660
DomainFERM_2

MYO10 FARP2 FARP1

4.87e-03501283PS00661
DomainFERM_3

MYO10 FARP2 FARP1

4.87e-03501283PS50057
DomainBand_41_domain

MYO10 FARP2 FARP1

4.87e-03501283IPR019749
DomainB41

MYO10 FARP2 FARP1

4.87e-03501283SM00295
Domain-

MPP2 RAB9B DICER1 TJP1 YLPM1 SMARCA4 ABCC12 SLFN11 GNAS SNRNP200 RAB27A DYNC1H1

5.21e-03746128123.40.50.300
DomainLaminin_N

LAMC1 LAMC3

5.25e-03161282IPR008211
DomainLamNT

LAMC1 LAMC3

5.25e-03161282SM00136
Domain-

RASA4 RASA4B

5.25e-031612821.10.506.10
DomainLAMININ_NTER

LAMC1 LAMC3

5.25e-03161282PS51117
DomainLaminin_N

LAMC1 LAMC3

5.25e-03161282PF00055
DomainSH3_1

ARHGAP32 SORBS2 ARHGAP10 PLCG1 PLCG2

5.46e-031641285PF00018
DomainIGc2

MAG IGFN1 MYLK MYOM3 HEPACAM2 ROBO1

5.65e-032351286SM00408
DomainIg_sub2

MAG IGFN1 MYLK MYOM3 HEPACAM2 ROBO1

5.65e-032351286IPR003598
Domain-

MAG IGFN1 MYLK MYOM3 HEPACAM2 BTN2A1 BTN2A2 PLXNC1 ROBO1 IL2RG TNXB

5.92e-03663128112.60.40.10
DomainPI-PLC-X

PLCG1 PLCG2

6.64e-03181282PF00388
DomainHATPase_c

MORC2 TOP2B

6.64e-03181282SM00387
PathwayREACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS

BTN2A1 BTN2A2 BTN2A3P

2.91e-0591013MM15487
PathwayWP_ENDOTHELIN_PATHWAYS

CAD MYLK ADRA1A GNAS

8.66e-05331014M39651
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY

CAMK1 PLCG1 PLCG2

1.23e-04141013M47386
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY

CAMK1 PLCG1 PLCG2

1.23e-04141013M47388
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY

CAMK1 PLCG1 PLCG2

1.53e-04151013M47385
Pubmed

A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.

INS PRKDC IL2RG INS-IGF2

3.05e-096133418563383
Pubmed

Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.

INS PRKDC IL2RG INS-IGF2

3.05e-096133420570944
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

MPP2 ARHGAP32 CAD SORBS2 HECW1 DVL2 GRM4 SHANK3 CCDC88A AGO3 TJP1 FARP1 YLPM1 DCHS1 SMARCA4 TJAP1 PRKD1 DYNC1H1 PHACTR1

5.24e-099631331928671696
Pubmed

Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell-Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice.

INS PRKDC INS-IGF2

5.47e-083133332005704
Pubmed

Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

INS PRKDC INS-IGF2

5.47e-083133317607359
Pubmed

Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.

BTN2A1 BTN2A2 BTN2A3P

5.47e-083133337356345
Pubmed

RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption.

BTN2A1 BTN2A2 BTN2A3P

5.47e-083133334421818
Pubmed

Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.

INS PRKDC INS-IGF2

5.47e-083133322427377
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

JCAD ARHGAP32 AMER1 DVL2 CEP192 PHKB C1orf198 CCDC88A FBN2 AGO3 TJP1 FARP1 CGN DYNC1H1 CFAP97 CBX8

1.85e-078531331628718761
Pubmed

Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.

INS MKRN1 PFKL FARP2 SLC25A12 SDHAF2 TJP1 SCNN1G KAT6B RAB27A INS-IGF2

2.08e-073711331115747579
Pubmed

Btn2a2 Regulates ILC2-T Cell Cross Talk in Type 2 Immune Responses.

BTN2A1 BTN2A2 BTN2A3P

2.18e-074133335145516
Pubmed

M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.

INS PRKD1 INS-IGF2

2.18e-074133321078968
Pubmed

Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice.

INS IL2RG INS-IGF2

2.18e-074133321926555
Pubmed

Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.

BTN2A1 BTN2A2 BTN2A3P

2.18e-074133326809444
Pubmed

Gsα-dependent signaling is required for postnatal establishment of a functional β-cell mass.

INS GNAS INS-IGF2

2.18e-074133334091063
Pubmed

Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes.

BTN2A1 BTN2A2 BTN2A3P

2.18e-074133323589618
Pubmed

Disrupted glucose homeostasis and glucagon and insulin secretion defects in Robo βKO mice.

INS ROBO1 INS-IGF2

2.18e-074133337498234
Pubmed

Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells.

INS ROBO1 INS-IGF2

2.18e-074133334231467
Pubmed

Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction.

INS IL2RG INS-IGF2

2.18e-074133333205073
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

CAD SRSF2 LAMC1 PFKL DICER1 NCBP3 TJP1 CGN YLPM1 SMARCA4 PKP1 PRKDC GNAS SNRNP200 TARS1 DYNC1H1 TOP2B

4.12e-0710241331724711643
Pubmed

Genomic organization, expression, and chromosomal mapping of the mouse adrenomedullin gene.

INS ADM INS-IGF2

5.44e-07513338938454
Pubmed

Dynamic recruitment of functionally distinct Swi/Snf chromatin remodeling complexes modulates Pdx1 activity in islet β cells.

INS SMARCA4 INS-IGF2

5.44e-075133325801033
Pubmed

The Akt substrate Girdin is a regulator of insulin signaling in myoblast cells.

INS CCDC88A INS-IGF2

5.44e-075133323886629
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

JCAD ARHGAP32 CAD ARHGAP10 DUSP8 CEP192 IDE PHKB CCDC88A TJP1 FARP1 CGN YLPM1 PNMA2 ROBO1 SLFN11 CBX8

5.75e-0710491331727880917
Pubmed

Expression and role of laminin-1 in mouse pancreatic organogenesis.

INS LAMC1 INS-IGF2

1.08e-066133310866045
Pubmed

BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation.

BTN2A1 BTN2A2 BTN2A3P

1.08e-066133320208008
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

JCAD ARHGAP32 SORBS2 AMER1 LAMC1 CEP192 DPP8 WNK1 DENND2B CCDC88A TJP1 CGN GNAS CFAP97 MAP3K2

1.15e-068611331536931259
Pubmed

The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis.

INS TJP1 INS-IGF2

1.89e-067133316542650
Pubmed

Dicer is required for maintaining adult pancreas.

INS DICER1 INS-IGF2

1.89e-067133319148298
Pubmed

The cluster of BTN genes in the extended major histocompatibility complex.

BTN2A1 BTN2A2 BTN2A3P

1.89e-067133311170752
Pubmed

Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.

INS DICER1 INS-IGF2

1.89e-067133325944670
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

AMER1 SRSF2 MYO10 DVL2 MON1A GMIP WNK1 FARP2 C1orf198 CCDC88A FBXO9 AGO3 TJP1 TJAP1 GNAS IL33

2.42e-0610381331626673895
Pubmed

Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.

PRKD1 PLCG1 PLCG2

3.02e-06813338885868
Pubmed

Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2.

INS SCNN1G INS-IGF2

3.02e-068133317715136
Pubmed

Glucocorticoid signalling affects pancreatic development through both direct and indirect effects.

INS PRKDC INS-IGF2

3.02e-068133317001468
Pubmed

WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding.

INS WNK1 INS-IGF2

3.02e-068133315350218
Pubmed

METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.

MPP2 SRSF2 SLC25A12 SRSF8 PRKDC GNAS SNRNP200 TOP2B

3.22e-06231133836597993
Pubmed

Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.

CAD SPTLC1 CCDC88A FARP1 CGN SMARCA4 ROBO1 PRKDC TARS1 DYNC1H1

3.40e-063991331037536630
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

CPAMD8 AMER1 ARHGAP10 CEP192 IDE PFKL DENND2B ZNF440 FARP2 PHKB EXD3 DPP9 TJP1 FARP1 TJAP1 PRKD1 PLCG1 GNAS KAT6B

4.12e-0614891331928611215
Pubmed

Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.

INS LAMC1 COL22A1 FBN2 NID1 TNXB INS-IGF2

5.29e-06175133728071719
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

CAD WNK1 FARP2 CGN PRKDC SNRNP200 DYNC1H1 MAP3K2

6.66e-06255133815324660
Pubmed

Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis.

INS DVL2 TJP1 INS-IGF2

6.76e-0632133423177622
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

JCAD TTC39B CAD SRSF2 PSKH1 SPTLC1 COL22A1 MORC2 DCHS1 SMARCA4 PLCG2 SNRNP200 DYNC1H1

6.93e-067541331335906200
Pubmed

Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin gamma1 chain.

LAMC1 LAMC3 NID1

8.82e-0611133321084308
Pubmed

Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors.

NKX6-2 INS INS-IGF2

8.82e-0611133320627083
Pubmed

Gfi1 Loss Protects against Two Models of Induced Diabetes.

NKX6-2 INS INS-IGF2

8.82e-0611133334831029
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

JCAD SORBS2 AMER1 CEP192 WNK1 TJP1 CGN PNMA2 PRKDC MAP3K2

9.02e-064461331024255178
Pubmed

Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.

CAD SORBS2 ARHGAP10 PFKL CGN PRKDC DYNC1H1

9.05e-06190133715161933
Pubmed

Syntenic organization of the mouse distal chromosome 7 imprinting cluster and the Beckwith-Wiedemann syndrome region in chromosome 11p15.5.

INS DUSP8 INS-IGF2

1.17e-051213339618174
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

CAD LAMC1 DICER1 PHKB PRKDC SNRNP200 TOP2B

1.35e-05202133733005030
Pubmed

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.

PRKDC IL2RG

1.45e-052133228115719
Pubmed

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes.

INS INS-IGF2

1.45e-052133237520739
Pubmed

Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia.

INS INS-IGF2

1.45e-052133219111542
Pubmed

Growth factors and medium hyperglycemia induce Sox9+ ductal cell differentiation into β cells in mice with reversal of diabetes.

INS INS-IGF2

1.45e-052133226733677
Pubmed

Progressive Thinning of Retinal Nerve Fiber Layer/Ganglion Cell Layer (RNFL/GCL) as Biomarker and Pharmacological Target of Diabetic Retinopathy.

INS INS-IGF2

1.45e-052133237628852
Pubmed

Decreased Satellite Cell Number and Function in Humans and Mice With Type 1 Diabetes Is the Result of Altered Notch Signaling.

INS INS-IGF2

1.45e-052133227335233
Pubmed

Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice.

INS INS-IGF2

1.45e-052133214688305
Pubmed

Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy.

INS INS-IGF2

1.45e-052133230480744
Pubmed

Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure.

PRKDC IL2RG

1.45e-052133237936122
Pubmed

The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice.

INS INS-IGF2

1.45e-052133234845324
Pubmed

Genetic control of insulin receptors.

INS INS-IGF2

1.45e-05213327031649
Pubmed

Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.

INS INS-IGF2

1.45e-052133216289958
Pubmed

Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism.

DPP8 DPP9

1.45e-052133223519473
Pubmed

Improved multilineage human hematopoietic reconstitution and function in NSGS mice.

PRKDC IL2RG

1.45e-052133230540841
Pubmed

Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.

DPP8 DPP9

1.45e-052133233932609
Pubmed

Insulin rescues impaired spermatogenesis via the hypothalamic-pituitary-gonadal axis in Akita diabetic mice and restores male fertility.

INS INS-IGF2

1.45e-052133222522616
Pubmed

Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.

INS INS-IGF2

1.45e-052133227855634
Pubmed

Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune system.

PRKDC IL2RG

1.45e-052133229549333
Pubmed

Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease.

INS INS-IGF2

1.45e-052133226203118
Pubmed

Maternal Chromium Restriction Leads to Glucose Metabolism Imbalance in Mice Offspring through Insulin Signaling and Wnt Signaling Pathways.

INS INS-IGF2

1.45e-052133227782077
Pubmed

PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration.

PRKD1 PRKDC

1.45e-052133217707375
Pubmed

Identification of novel diabetes impaired miRNA-transcription factor co-regulatory networks in bone marrow-derived Lin-/VEGF-R2+ endothelial progenitor cells.

INS INS-IGF2

1.45e-052133229995913
Pubmed

Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis.

INS INS-IGF2

1.45e-052133215718275
Pubmed

Insulin-Deficient Mouse β-Cells Do Not Fully Mature but Can Be Remedied Through Insulin Replacement by Islet Transplantation.

INS INS-IGF2

1.45e-052133229029025
Pubmed

Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.

INS INS-IGF2

1.45e-052133220948967
Pubmed

Prevalence and Clinical Characteristics of PDX1 Variant Induced Diabetes in Chinese Early-Onset Type 2 Diabetes.

INS INS-IGF2

1.45e-052133237279936
Pubmed

An imprinted GFP insertion reveals long-range epigenetic regulation in embryonic lineages.

INS INS-IGF2

1.45e-052133219778534
Pubmed

Insulin Knockout Mice Have Extended Survival but Volatile Blood Glucose Levels on Leptin Therapy.

INS INS-IGF2

1.45e-052133226696124
Pubmed

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice.

PRKDC IL2RG

1.45e-052133239346922
Pubmed

Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination.

INS IDE

1.45e-052133229273204
Pubmed

Compensatory hyperinsulinemia in high-fat diet-induced obese mice is associated with enhanced insulin translation in islets.

INS INS-IGF2

1.45e-052133225686499
Pubmed

Parental diabetes: the Akita mouse as a model of the effects of maternal and paternal hyperglycemia in wildtype offspring.

INS INS-IGF2

1.45e-052133223209676
Pubmed

Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R.

PLCG1 PLCG2

1.45e-052133212471105
Pubmed

Hyper-Variability in Circulating Insulin, High Fat Feeding Outcomes, and Effects of Reducing Ins2 Dosage in Male Ins1-Null Mice in a Specific Pathogen-Free Facility.

INS INS-IGF2

1.45e-052133227055260
Pubmed

Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.

INS INS-IGF2

1.45e-052133219801494
Pubmed

Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice.

INS INS-IGF2

1.45e-052133233667544
Pubmed

Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2.

INS INS-IGF2

1.45e-05213327729600
Pubmed

Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.

PRKDC IL2RG

1.45e-052133220668220
Pubmed

Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

INS INS-IGF2

1.45e-052133222015457
Pubmed

Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.

DPP8 DPP9

1.45e-052133226242871
Pubmed

Impact of genetic background on nephropathy in diabetic mice.

INS INS-IGF2

1.45e-052133216118394
Pubmed

High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications.

INS INS-IGF2

1.45e-052133223391566
Pubmed

The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression.

PRKDC IL2RG

1.45e-052133238428396
Pubmed

Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.

DPP8 DPP9

1.45e-052133222736146
Pubmed

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.

PRKDC IL2RG

1.45e-052133236215121
Pubmed

Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.

PRKDC IL2RG

1.45e-052133223643966
Pubmed

A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.

INS INS-IGF2

1.45e-052133217151334
Pubmed

Dynamic Ins2 Gene Activity Defines β-Cell Maturity States.

INS INS-IGF2

1.45e-052133236170671
Pubmed

Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages.

INS INS-IGF2

1.45e-052133223894189
Pubmed

Metabolic effects of short-term caloric restriction in mice with reduced insulin gene dosage.

INS INS-IGF2

1.45e-052133229439088
InteractionYWHAG interactions

JCAD ARHGAP32 CAD SORBS2 AMER1 DVL2 CEP192 WNK1 DENND2B SHANK3 FARP2 CCDC88A TJP1 SRSF8 CGN PRKD1 SLFN11 PRKDC GNAS SNRNP200 DYNC1H1 CFAP97 MAP3K2

5.22e-06124813123int:YWHAG
GeneFamilyRho GTPase activating proteins|BCH domain containing

ARHGAP32 ARHGAP36 ARHGAP10 GMIP ARHGAP27

6.01e-0650945721
GeneFamilyButyrophilins|V-set domain containing|C2-set domain containing

BTN2A1 BTN2A2 BTN2A3P

5.92e-0515943458
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

MYO10 FARP2 FARP1 RASA4B PRKD1 PLCG1 ARHGAP27

9.97e-05206947682
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLA2G4B PLCG1 PLCG2

1.24e-0419943832
GeneFamilyFibronectin type III domain containing

IGFN1 MYLK MYOM3 ROBO1 IL2RG TNXB

1.87e-04160946555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MAG IGFN1 MYLK MYOM3 HEPACAM2 ROBO1

1.94e-04161946593
GeneFamilyCD molecules|DASH family

DPP8 DPP9

5.52e-0479421205
GeneFamilyC2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors

MAG BTN2A1 BTN2A2

1.17e-0340943592
GeneFamilyPleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing

RASA4 RASA4B

1.17e-0310942830
GeneFamilyPhospholipases

PLA2G4B PLCG1 PLCG2

1.35e-0342943467
GeneFamilyX-linked mental retardation|RNA helicases

DICER1 SNRNP200

1.43e-03119421168
GeneFamilyRNA binding motif containing|Serine and arginine rich splicing factors

SRSF2 SRSF8

1.71e-0312942737
GeneFamilyLaminin subunits

LAMC1 LAMC3

1.71e-0312942626
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

MYO10 FARP2 FARP1

2.24e-03509431293
GeneFamilyCalcium voltage-gated channel subunits|Membrane associated guanylate kinases

MPP2 TJP1

8.01e-0326942904
GeneFamilyPDZ domain containing

MPP2 DVL2 SHANK3 TJP1

8.16e-031529441220
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYLK MYO10 LAMC1 ADRA1A ROBO1 NID1 PRKD1 TNXB

1.23e-07193133899525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

MYLK MYO10 LAMC1 ADRA1A ROBO1 NID1 PRKD1 TNXB

1.33e-071951338603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellfacs-Marrow-B-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 INS SLC43A1 MKRN1 DUSP8 ISG20 FN3K

6.36e-07164133718eeda51e69722992c3a7f699be293535a90868b
ToppCellIonocyte-iono-1|World / Class top

DUSP8 HEPACAM2 CAMK1 RASA4 PDILT PLCG2 GNAS

7.79e-0716913374b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGAP10 DENND2B ADRA1A FBN2 FARP1 KIAA1755 NID1

9.47e-071741337f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 HECW1 COL22A1 FBN2 XIRP2 NRK ROBO1

1.38e-0618413372cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 HECW1 COL22A1 FBN2 XIRP2 NRK ROBO1

1.38e-061841337ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 HECW1 COL22A1 FBN2 XIRP2 NRK ROBO1

1.38e-0618413372b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

IGFN1 MYLK MYO10 LAMC1 ADRA1A ROBO1 TNXB

1.53e-061871337e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B ROBO1 NID1 IL33

1.70e-0619013371121eb607a984c59fbffe7220837fc178745aa55
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B ROBO1 NID1 IL33

1.70e-061901337048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYLK LAMC1 ADRA1A ROBO1 NID1 PRKD1 TNXB

1.76e-0619113376688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYLK LAMC1 ADRA1A ROBO1 NID1 PRKD1 TNXB

1.83e-06192133799ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYLK MYO10 LAMC1 ADRA1A NID1 PRKD1 TNXB

1.96e-061941337e93de9428c986b8943fc169258847c650cfab0e5
ToppCellCOVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type

LAMC1 NRK KIAA1755 ROBO1 NID1 TNXB IL33

2.02e-061951337f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

SORBS2 MYOM3 ADRA1A FBN2 ST3GAL6 XIRP2 PHACTR1

2.02e-06195133775fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

JCAD MYO10 SHANK3 TJP1 DCHS1 NID1 IL33

2.24e-0619813372630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

JCAD MYO10 SHANK3 TJP1 DCHS1 NID1 IL33

2.24e-0619813371e83bec16dcd60460422625f89952ff506d6be51
ToppCell10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD MYO10 SHANK3 TJP1 DCHS1 NID1 IL33

2.32e-06199133741f046646fff65b7e51b63d3204f76ef32054781
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MPP2 MAG NKX6-2 MYLK C1orf198 TJP1 ROBO1

2.32e-0619913375d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MPP2 MAG NKX6-2 MYLK C1orf198 TJP1 ROBO1

2.32e-0619913379dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYLK MYO10 LAMC1 ROBO1 NID1 PRKD1 TNXB

2.32e-06199133730d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MPP2 MAG NKX6-2 MYLK C1orf198 TJP1 ROBO1

2.32e-0619913376fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MPP2 MAG NKX6-2 MYLK C1orf198 TJP1 ROBO1

2.32e-0619913371bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD MYO10 SHANK3 TJP1 DCHS1 NID1 IL33

2.32e-061991337ef7f7f7c861827574b120f48cf4052c563929081
ToppCellP03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

JCAD SLC43A1 MKRN1 ISG20 FN3K TJP1

4.75e-0614413362ee6a834860eac7ed004f366ab4fc38c4b80c905
ToppCellP03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

JCAD SLC43A1 MKRN1 ISG20 FN3K TJP1

4.75e-0614413369fa63904389f4d7163db22ea85ab721d8f6e8d99
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32

SLC43A1 LAMC3 COL22A1 NRK KIAA1755 TNXB

6.73e-061531336e9c6fb5c41adb6595c66c3a917fe455348279e54
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32

SLC43A1 LAMC3 COL22A1 NRK KIAA1755 TNXB

6.73e-061531336b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32

SLC43A1 LAMC3 COL22A1 NRK KIAA1755 TNXB

6.73e-0615313362513edfae62a44e51d3556675a096723194c966c
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ZNF862 POLE2 LAMC1 MON1A FN3K DEGS2

6.99e-0615413361c62290a2558fd6401b27de5a867d243b143b00a
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A1 MKRN1 ISG20 FN3K C1orf198 FBXO9

9.34e-06162133608ee7ae56e4927874515c47adc86dd845bf29a26
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INS SLC43A1 MKRN1 DUSP8 ISG20 FN3K

1.00e-051641336f3772227f5aa75a3672d945f8d5bf3fa0b4e456b
ToppCellfacs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 SLC43A1 MKRN1 DUSP8 ISG20 FN3K

1.15e-05168133608fe8fa43c343c03f9a2f0b982192fde04a7c027
ToppCellfacs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 SLC43A1 MKRN1 DUSP8 ISG20 FN3K

1.15e-051681336d4053b2fffb19e0376b8ceb92e87ec4447d96a3e
ToppCellfacs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 SLC43A1 MKRN1 DUSP8 ISG20 FN3K

1.23e-051701336b180ec9a1b79025a180c8559c27c31272410dea8
ToppCellfacs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPP2 SLC43A1 MKRN1 DUSP8 ISG20 FN3K

1.23e-05170133637c647f67505aa1ff12a198df1eeddd9f406fe15
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

CPAMD8 SORBS2 SHANK3 TJP1 PLCG2 IL33

1.27e-0517113361597459c971d6befa991d59dc66b41b6a522f797
ToppCelldroplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGAP32 ISG20 PLXNC1 ROBO1 NID1 ARHGAP27

1.75e-051811336fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCellRV|World / Chamber and Cluster_Paper

SORBS2 MYOM3 ADRA1A FBN2 XIRP2 PHACTR1

1.75e-051811336bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGAP10 LAMC1 NRK KIAA1755 NID1 TNXB

1.81e-0518213363dfa9187e9d2bab1d199079d29209c4648220ada
ToppCellCOVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SORBS2 MYOM3 ADRA1A FBN2 ST3GAL6 XIRP2

1.98e-051851336549eeb521c3985bff396ea0f202db21822efa51f
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

SORBS2 MYOM3 FBN2 ST3GAL6 XIRP2 PHACTR1

1.98e-0518513366baccb26f999145e51b91d94315bf8d4655bef31
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD MYO10 DPP8 TJP1 NRK DEGS2

2.04e-0518613360ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

MYLK ADRA1A ROBO1 NID1 PRKD1 TNXB

2.11e-05187133692d468dde81125d51daf7abd4703741abe1ab91c
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 SLC43A1 FBN2 NID1 TNXB IL33

2.11e-0518713364e553721fa5598cb211f44e3226280b7e6885484
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 SLC43A1 FBN2 NID1 TNXB IL33

2.11e-051871336d36e7fc6125e7a4310499365022d38f34b757a73
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 SLC43A1 FBN2 NID1 TNXB IL33

2.11e-051871336827eae63fabf6892a82ce7779b5f395958d3d628
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

MYLK HECW1 ARHGAP10 ROBO1 NID1 TNXB

2.11e-051871336bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellRV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

SORBS2 MYOM3 ADRA1A FBN2 XIRP2 PHACTR1

2.11e-05187133678cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCellCOVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

LAMC1 KIAA1755 ROBO1 NID1 TNXB IL33

2.17e-051881336fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCellLV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

SORBS2 MYOM3 ADRA1A FBN2 XIRP2 PHACTR1

2.17e-0518813360758b474457efa36488e0195f7357100f4b6a090
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMC1 LAMC3 DENND2B FBN2 FARP1 ROBO1

2.17e-051881336997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCellEndothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

JCAD MYOM3 SHANK3 DCHS1 TNXB IL33

2.17e-0518813360824d567356d360fd8e78e840c30529c139f98a1
ToppCellfacs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PFKL TJAP1 IL2RG TNXB IL33 RAB27A

2.17e-0518813368cc927b4c51d982fdafa04dc7393617ad9bb220e
ToppCelldroplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 MYLK SLC43A1 FBN2 TNXB IL33

2.24e-0518913361821ae4a6e37ee4c6308071883f3f447a7c53c53
ToppCelldroplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 MYLK SLC43A1 FBN2 TNXB IL33

2.24e-0518913361e4d7e8dc98b3d70351e6a6c2aaf9ca01f141b8f
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

SORBS2 MYOM3 ADRA1A FBN2 XIRP2 PHACTR1

2.24e-0518913365e80c47f63980904c4c1ff02c201b67b456a0974
ToppCelldroplet-Pancreas-PANCREAS-30m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKX6-2 MYLK SLC43A1 FBN2 TNXB IL33

2.24e-0518913361dc415ed41815f4296dafd8cf7f3e014c44db1db
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAB9B MYLK ARHGAP10 ADRA1A C1orf198 NID1

2.30e-0519013362e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class

MAG JCAD SHANK3 DCHS1 NID1 IL33

2.30e-051901336bce09634acbc2cfd53666328e8aed8bf8835f845
ToppCellPND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass

JCAD DENND2B SHANK3 ST3GAL6 TJP1 IL2RG

2.30e-0519013361357bd4527399d7013ee33272bda7453f472999a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAB9B MYLK ARHGAP10 ADRA1A C1orf198 NID1

2.30e-0519013360028f886c789ba238c031eae5d96acaed4af8c25
ToppCellPND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass

JCAD DENND2B SHANK3 ST3GAL6 TJP1 IL2RG

2.30e-0519013365130fb325f80f591b9b36beacb8072c4472304f2
ToppCell5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

JCAD SHANK3 RASA4 PKP1 RASA4B IL33

2.30e-051901336141266bf411ea675fbf889b20c1b08673c45ff95
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

MYLK ARHGAP10 ADRA1A ROBO1 NID1 TNXB

2.30e-0519013363a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class

MAG JCAD SHANK3 DCHS1 NID1 IL33

2.30e-05190133608437396a98ca9526f69c3a74bbf2929f3c68b8e
ToppCellfacs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A1 ADM FBN2 KIAA1755 NID1 TNXB

2.44e-0519213368937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCellfacs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A1 ADM FBN2 KIAA1755 NID1 TNXB

2.44e-051921336e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCellfacs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A1 ADM FBN2 KIAA1755 NID1 TNXB

2.44e-051921336ac1477433704573f95111eee6263b93668d2845e
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

SORBS2 MYOM3 ADRA1A ST3GAL6 XIRP2 PHACTR1

2.52e-051931336dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYLK MYO10 LAMC1 NID1 PRKD1 TNXB

2.52e-051931336b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

IGFN1 CPNE9 LCT MMEL1 XIRP2

2.58e-0511613359c92e714e210a2f29a9e228653d4c990ec643c72
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

JCAD SORBS2 MYO10 LAMC1 SHANK3 NID1

2.59e-051941336ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

JCAD SORBS2 MYO10 LAMC1 SHANK3 NID1

2.59e-051941336cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

MYLK LAMC1 ADRA1A ROBO1 NID1 TNXB

2.67e-05195133661c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAG NKX6-2 ISG20 DICER1 FN3K C1orf198

2.67e-0519513361e28617ca55e5f318a228357737b968dfac8cca0
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

MYLK LAMC1 ADRA1A ROBO1 NID1 PRKD1

2.67e-051951336aa0add081881d349099d12efca5cdee098038d4e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAB9B MYLK ARHGAP10 ADRA1A KIAA1755 NID1

2.74e-0519613361522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPTLC1 LAMC1 ADM FARP1 KIAA1755 NID1

2.74e-05196133685507488f83d8f71b3ee2ad5e5aa0b6ad6193873
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAB9B MYLK ARHGAP10 ADRA1A KIAA1755 NID1

2.74e-0519613361c8294014713684b50885e638668f2ce75f357f0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JCAD SHANK3 ROBO1 TNXB IL33 PHACTR1

2.74e-051961336e224338490691d92c1f70b57112fabdcc92b06a9
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYLK LAMC1 ADRA1A ROBO1 NID1 TNXB

2.74e-0519613367d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B KIAA1755 NID1

2.82e-05197133685a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

JCAD SHANK3 TJP1 DCHS1 NID1 IL33

2.82e-0519713364e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B KIAA1755 NID1

2.82e-051971336e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

JCAD LAMC1 SHANK3 TJP1 NID1 IL33

2.82e-051971336b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B ROBO1 NID1

2.82e-0519713369b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAJC25 LAMC1 MMEL1 NID1 GNAS TNXB

2.90e-0519813365e70246a9ce199cb2fb5379912b8ab59456219e4
ToppCell10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

JCAD SHANK3 TJP1 DCHS1 NID1 IL33

2.90e-051981336122215d9288533ad03562cf777e846504863df9a
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

MYLK LAMC1 ADRA1A ROBO1 NID1 TNXB

2.90e-05198133626e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMC1 LAMC3 DENND2B ROBO1 NID1

2.90e-051981336a860246bcea847249a78fd2e86ed8e04371060db
ToppCell10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

JCAD SHANK3 TJP1 DCHS1 NID1 IL33

2.90e-051981336307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMC1 DENND2B FARP1 NRK KIAA1755 NID1

2.90e-05198133675d104eead681f6bf47c4dd24913cc768c9a1717
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

MYLK LAMC1 ADRA1A ROBO1 NID1 PRKD1

2.90e-051981336df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYLK LAMC1 ADRA1A ROBO1 NID1 TNXB

2.90e-0519813368f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMC1 FBN2 FARP1 NRK KIAA1755 NID1

2.99e-051991336e78f661b40da34768469549b6e755d330be6bbd8
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MYLK LAMC1 ROBO1 NID1 PRKD1 TNXB

3.07e-0520013369b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD SHANK3 TJP1 DCHS1 NID1 IL33

3.07e-0520013362488aa12970a43a5af352e2c36c73884d73a1cc5
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ARHGAP32 SORBS2 DENND2B TJP1 CGN PKP1

3.07e-05200133697f36d2c197e03d93a1fc59949d77ae90f6e6a9a
DrugRgd Peptide

MYO10 LAMC1 LAMC3 DPP8 FBN2 DPP9 DCHS1 NID1 PLCG2 TNXB

1.11e-0623912910CID000104802
DrugCefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A

MYLK ZNF862 PSKH1 DUSP8 FARP2 CCDC88A PKP1 TJAP1 PLCG1

2.06e-0619912995787_DN
DrugI-Q-S

MYLK PCLAF LAMC1 LAMC3 CAMK1 CGN NID1 PRKD1

3.07e-061561298CID000003540
Druggrayanotoxin I

NKX6-2 CCDC88A CGN IL2RG

6.65e-06221294CID000020842
DrugD-myo-inositol 1,4-bisphosphate

PCLAF INS ADRA1A PRKD1 PLCG1 PLCG2

9.55e-06861296CID000000805
DrugAC1L1KC5

MAG MYLK PCLAF INS ISG20 CAMK1 GRM4 CHRNB1 NRK PRKD1 PLCG2 IL2RG CBX8

1.27e-0554112913CID000005428
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A

MYO10 ZNF862 DUSP8 DVL2 TRMO WNK1 DICER1 RAB27A

1.52e-0519412984309_DN
DrugLansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A

HECW1 ARHGAP10 DENND2B BTN2A2 ADRA1A ST3GAL6 IL2RG PHACTR1

1.58e-0519512983529_UP
DrugAC1L1KMJ

MYLK INS LAMC1 LAMC3 COL22A1 TJP1 NRK CGN PRKD1 PLCG1 PLCG2 MAP3K2

1.74e-0547612912CID000030956
DrugAC1MJ4IO

MAG LCT ST3GAL6 PRKDC IL2RG

2.30e-05601295CID003085448
DrugPkcs

MYLK PCLAF INS WNK1 PRKD1 PLCG1 PRKDC PLCG2

2.78e-052111298CID000164073
DrugHormothamnin A

FBN2 TOP2B

3.19e-0521292CID006440066
DrugUAMC00132

DPP8 DPP9

3.19e-0521292ctd:C524159
DrugNDGA

MAG PCLAF INS NRK PRKD1 PLCG1 PLCG2 CBX8

3.29e-052161298CID000004534
Drugsampatrilat

DPP8 MMEL1 DPP9

4.88e-05131293CID006324648
Drugadenosine 3',5'-cyclic phosphate

MYLK PCLAF INS POLE2 CAMK1 PFKL GRM4 ADM PHKB ADRA1A PRKD1 PLCG1 PLCG2 GNAS IL2RG MAP3K2

5.57e-0590712916CID000000274
Drugmyo-inositol

MYLK PCLAF INS PFKL LCT GRM4 CHRNB1 ADM ADRA1A RASA4 NRK PRKD1 PLCG1 PLCG2 GNAS

5.69e-0581112915CID000000892
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MPP2 ZNF862 DVL2 ISG20 ADM TJAP1 CBX8

5.94e-051731297995_UP
DrugRo 32-0432

INS ADRA1A TJP1

6.18e-05141293ctd:C085989
Drug(2S,3R)-Sphingosine

MYLK PCLAF INS SPTLC1 DENND2B CHRNB1 PRKD1 PLCG1 PLCG2 DEGS2

7.65e-0538912910CID000001104
DrugAC1L9GJJ

RASA4 PRKD1 PLCG1 PLCG2

7.67e-05401294CID000444570
Drugmethyl 2,5-dihydroxycinnamate

MYLK PCLAF PRKD1 RAB27A TOP2B

7.70e-05771295CID000003248
Drug8-isoprostaglandin E1

PCLAF INS POLE2 ADM ADRA1A PLCG1 PLCG2 GNAS

9.44e-052511298CID000000214
DrugSureCN3749646

DPP8 DPP9

9.52e-0531292CID011530920
Drug6alpha-ethyl-23(S)-methylcholic acid

INS GNAS

9.52e-0531292ctd:C545501
DrugSureCN3745540

DPP8 DPP9

9.52e-0531292CID011974437
DrugSureCN3749947

DPP8 DPP9

9.52e-0531292CID011974435
DrugABT-279

DPP8 DPP9

9.52e-0531292CID016049769
DrugCyanopyrrolidine 39

DPP8 DPP9

9.52e-0531292CID011117606
DrugVasopressins

MYLK INS

9.52e-0531292ctd:D014667
DrugSpasmalgon

FARP2 ADM

9.52e-0531292CID000165701
DrugCyanopyrrolidine 38

DPP8 DPP9

9.52e-0531292CID010932707
DrugSureCN3748611

DPP8 DPP9

9.52e-0531292CID011974325
DrugDiprolyl-alanine

DPP8 DPP9

9.52e-0531292CID000193559
Drugoxotremorine-M

INS CHRNB1 PLCG1 PLCG2 GNAS

9.80e-05811295CID000004629
Drug6-thioguanine

INS POLE2 PRTFDC1 PNMA2 ABCC12 TOP2B

9.89e-051301296CID002723601
Drugisoproterenol

MYLK PCLAF MYO10 INS SPTLC1 ISG20 CHRNB1 ADM ADRA1A SCNN1G PRKD1 GNAS IL2RG

1.12e-0466912913CID000003779
Drug4-AP

PCLAF INS ISG20 GRM4 CGN SCNN1G PRKD1 IL2RG

1.14e-042581298CID000001727
Drugfelodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA

MPP2 SEMA4F ARHGAP32 ARHGAP10 GMIP PHKB PLCG1

1.18e-041931297965_DN
DrugFlucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

JCAD CAMK1 DENND2B PLXNC1 NID1 IL2RG CBX8

1.22e-0419412976507_UP
DrugI11-0029

INS DPP8 DPP9 SCNN1G

1.22e-04451294CID005251896
DrugCP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A

SEMA4F ARHGAP32 HECW1 GAL3ST4 ISG20 GRM4 IL33

1.26e-0419512974557_UP
DrugPrazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

JCAD GAL3ST4 GMIP BTN2A1 BTN2A2 PKP1 PRKD1

1.30e-0419612976315_DN
Drug6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A

MPP2 MORC2 ADM SMARCA4 PLCG1 PRKDC CBX8

1.30e-0419612974833_UP
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

ZNF862 DUSP8 ISG20 DICER1 BTN2A1 FARP1 CBX8

1.30e-0419612972889_DN
DrugTropine [120-29-6]; Down 200; 28.4uM; HL60; HT_HG-U133A

ZNF862 DUSP8 ISG20 EXD3 ST3GAL6 PLXNC1 TJAP1

1.30e-0419612976147_DN
DrugClemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A

MPP2 ZNF862 WNK1 PLCG1 PLCG2 RAB27A CBX8

1.34e-0419712972301_DN
DrugRC-4

INS IDE CBX8

1.36e-04181293CID000095892
Drugpinacidil

INS IDE ADM SCNN1G PRKD1

1.38e-04871295CID000004826
DrugLysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A

DVL2 EXD3 FBXO9 SMARCA4 TJAP1 PLCG1 CBX8

1.38e-0419812973261_DN
DrugN6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA

MPP2 SEMA4F DUSP8 ISG20 AGO3 ST3GAL6 CHPF2

1.38e-041981297842_DN
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HG-U133A

SEMA4F ARHGAP10 SLC43A1 CEP192 DENND2B BTN2A2 CHPF2

1.38e-041981297121_DN
DrugGlycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A

ZNF862 TRMO MORC2 BTN2A2 EXD3 PLCG1 IL33

1.38e-0419812973687_DN
DrugBrinzolamide [138890-62-7]; Down 200; 10.4uM; HL60; HG-U133A

PSKH1 TRMO CCDC88A SLC25A12 YLPM1 CHPF2 KAT6B

1.38e-0419812971615_DN
DrugGTP[S]

MYLK PCLAF INS GRM4 ADM ADRA1A NRK SCNN1G PRKD1 PLCG1 PLCG2 GNAS

1.39e-0459112912CID000001764
DrugBenzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A

HECW1 ZNF862 DUSP8 FARP2 TJAP1 NID1 GNAS

1.47e-0420012976839_UP
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A

SEMA4F ISG20 CAMK1 EXD3 PLXNC1 TJAP1 MAP3K2

1.47e-0420012973904_DN
DrugBupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A

ARHGAP32 MYLK ZNF862 WNK1 FARP2 BTN2A2 TJAP1

1.47e-0420012975782_DN
Drugprocaterol

PCLAF ADRA1A PRKD1 GNAS

1.58e-04481294CID000004916
DiseasePseudohypoaldosteronism, Type I

WNK1 SCNN1G GNAS

8.93e-06101263C0268436
DiseasePseudohypoaldosteronism

WNK1 SCNN1G GNAS

8.93e-06101263C0033805
DiseaseHyperpotassemia and Hypertension, Familial

WNK1 SCNN1G GNAS

8.93e-06101263C2713447
DiseasePseudohypoaldosteronism, Type I, Autosomal Recessive

WNK1 SCNN1G GNAS

8.93e-06101263C1449843
DiseasePseudohypoaldosteronism, Type II

WNK1 SCNN1G GNAS

8.93e-06101263C1449844
DiseasePseudohypoaldosteronism, Type I, Autosomal Dominant

WNK1 SCNN1G GNAS

8.93e-06101263C1449842
Disease22q13.3 Deletion Syndrome

INS SHANK3

1.81e-0521262C1853490
DiseaseSex Cord-Stromal Tumor

DICER1 GNAS

1.81e-0521262C0206724
DiseaseHereditary Motor and Sensory-Neuropathy Type II

SPTLC1 MORC2 WNK1

2.11e-05131263C0270914
DiseaseColorectal Carcinoma

CPAMD8 CAD LAMC1 WNK1 FBN2 PDILT DCHS1 SCNN1G NID1 PRKD1 GNAS SNRNP200

4.93e-0570212612C0009402
DiseaseSezary Syndrome

SMARCA4 PLCG1 IL2RG

2.06e-04271263C0036920
DiseaseSchizophrenia

MAG ARHGAP32 IDE GRM4 DICER1 SHANK3 ADM ADRA1A PLA2G4B GNAS IL2RG TNXB

4.12e-0488312612C0036341
Diseasepseudohypoaldosteronism (is_implicated_in)

WNK1 SCNN1G

4.98e-0481262DOID:4479 (is_implicated_in)
Diseasecytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant

EXD3 NID1

4.98e-0481262EFO_0001062, EFO_0007044
Diseaseautism spectrum disorder (implicated_via_orthology)

ARHGAP32 LAMC1 LAMC3 SHANK3 PKP1

5.03e-041521265DOID:0060041 (implicated_via_orthology)
Diseasecortical surface area measurement

CPAMD8 LAMC1 GAL3ST4 LAMC3 COL22A1 PRTFDC1 CCDC88A FBN2 TJP1 KIAA1755 ROBO1 PRKD1 ARHGAP27 TNXB INS-IGF2

6.31e-04134512615EFO_0010736
DiseaseGlaucoma

CPAMD8 MYLK

6.39e-0491262C0017601
DiseasePituitary Adenoma

DICER1 GNAS

6.39e-0491262C0032000
Diseaselatent autoimmune diabetes in adults, type 2 diabetes mellitus

INS INS-IGF2

6.39e-0491262EFO_0009706, MONDO_0005148
Diseasephysical activity measurement

MKRN1 MYOM3 EXD3 FARP1 CBX8 PHACTR1

6.62e-042451266EFO_0008002
Diseaseurinary uromodulin measurement

SLC25A12 PDILT DYNC1H1 PHACTR1

7.77e-04961264EFO_0005663
Diseasegastroesophageal reflux disease

MON1A BTN2A1 FARP1 YLPM1

9.40e-041011264EFO_0003948
DiseaseCharcot-Marie-Tooth Disease

SPTLC1 MORC2

1.16e-03121262C0007959
Diseasefactor VIII measurement, coronary artery disease

JCAD BTN2A1 SMARCA4 PHACTR1

1.43e-031131264EFO_0001645, EFO_0004630
Diseaseserum urea measurement

INS DVL2 PDILT GNAS INS-IGF2

1.53e-031951265EFO_0009795
DiseaseMetastatic melanoma

CAMK1 PRKD1 PRKDC

1.61e-03541263C0278883
DiseaseChronic Lymphocytic Leukemia

SRSF2 FARP2 PLCG2

1.70e-03551263C0023434
Diseasecoronary artery disease

JCAD TTC39B SORBS2 LAMC1 DENND2B PRTFDC1 FBN2 FARP1 SMARCA4 PLCG1 PLCG2 TNXB PHACTR1

1.82e-03119412613EFO_0001645
DiseaseAlzheimer's disease (biomarker_via_orthology)

INS IDE INS-IGF2

1.98e-03581263DOID:10652 (biomarker_via_orthology)
Diseasemigraine without aura, susceptibility to, 4

MPP2 PHACTR1

2.09e-03161262MONDO_0011847
Diseaseuridine diphosphate galactose measurement, uridine diphosphate glucose measurement

JCAD IGFN1

2.36e-03171262EFO_0010543, EFO_0010544
DiseaseTachycardia

INS GNAS

2.65e-03181262C0039231
DiseaseTachyarrhythmia

INS GNAS

2.65e-03181262C0080203
Diseaseosteoarthritis

MPP2 MYLK HECW1 LCT KIAA1755

2.69e-032221265MONDO_0005178
Diseasecortical thickness

CPAMD8 LAMC1 LAMC3 PRTFDC1 CCDC88A FBN2 PLXNC1 YLPM1 KIAA1755 ROBO1 INS-IGF2 CBX8

2.95e-03111312612EFO_0004840
Diseasefacial asymmetry measurement

MYO10 POLE2

2.95e-03191262EFO_0009751
DiseaseSevere Combined Immunodeficiency

PRKDC IL2RG

3.27e-03201262C0085110
Diseaseneurodegenerative disease (implicated_via_orthology)

DVL2 SCNN1G DEGS2 DYNC1H1

3.52e-031451264DOID:1289 (implicated_via_orthology)
Diseasestroke, coronary artery disease

SMARCA4 PHACTR1

3.60e-03211262EFO_0000712, EFO_0001645
DiseaseLewy Body Disease

MAG INS

3.95e-03221262C0752347
Diseasebasophil percentage of leukocytes

GMIP DPP8 AP5M1 PRKDC PHACTR1

3.96e-032431265EFO_0007992
Diseasemyocardial infarction

JCAD LAMC1 DENND2B SMARCA4 PLCG2 PHACTR1

3.99e-033501266EFO_0000612

Protein segments in the cluster

PeptideGeneStartEntry
SPAVFVYKGGRERTE

BTN2A3P

71

Q96KV6
VAPGKNYSFTREEVR

CFAP97

371

Q9P2B7
DAYRFVKDRRPSISP

DUSP8

271

Q13202
RIPVGSRETFYRISK

ADRA1A

376

P35348
ELVRDSPARKAVSRY

CALHM3

161

Q86XJ0
PKRMSVRGFDRYFSS

GRM4

336

Q14833
YVGESERAVRETFRK

SPATA5

701

Q8NB90
REKLFSGYDSSVRPA

CHRNB1

31

P11230
RDFRPLEKRYEGTCS

AMER1

696

Q5JTC6
GTPRDKAEMFRERYT

POLE2

121

P56282
VTIFGDRRPVYDGKR

AGO3

76

Q9H9G7
KFSPAERTYDGKVRV

DICER1

1866

Q9UPY3
DSFYRLEKRLGRSEP

DENND2B

251

P78524
VEGFPERREARKYAS

DVL2

466

O14641
EDSSPDAARIRVKRY

ADM

81

P35318
PFVRVRYKGRTRETS

RASA4

156

O43374
FREKRVVYRASGPDG

RAB27A

46

P51159
LVKRTSRSDGFRPDY

PRTFDC1

171

Q9NRG1
PFVRVRYKGRTRETS

RASA4B

156

C9J798
QERFKSLRTPFYRGA

RAB9B

66

Q9NP90
RVPREKEAKTGVSYF

ARHGAP36

531

Q6ZRI8
KFIRPEGEITDYRTR

ISG20

41

Q96AZ6
RGFFYTPKTRREAED

INS

46

P01308
SRGEIIDFSKHYRPR

KAT6B

451

Q8WYB5
ESIRSRKARAVYPCE

ARHGAP10

726

A1A4S6
QRDRYRFTAVTPDGA

DCHS1

111

Q96JQ0
RPRSLVDSKAYADAR

FAM189A1

476

O60320
EKSFRRSVVGTPAYL

PRKD1

736

Q15139
KFRVRAINVYGTSEP

MYLK

1401

Q15746
DFRISGAPEKYESER

MAG

561

P20916
YAAPVKGRFTISRDD

IGHV3-15

81

A0A0B4J1V0
GPEGRKRYSDIFRSL

GMIP

11

Q9P107
ESSEERPYNLGFRRK

KIAA1755

341

Q5JYT7
SARAPSPYRRDFEAK

HECW1

1216

Q76N89
DVPRVSTDAFYGRRK

JCAD

1136

Q9P266
DARDGVATKSIRPRY

SLC43A1

396

O75387
ARVAKYRAKFDPRVT

PSKH1

81

P11801
PLDDRERKRFTYFSS

C1orf198

21

Q9H425
GDFYDRRTTKPEFLR

CCDC88A

1741

Q3V6T2
KTMAYRELRPFSGRE

PNMA6F

246

A0A0J9YX94
REDPRFTGYRVESEV

PLXNC1

841

O60486
REVYRKGRVFANAPD

PFKL

691

P17858
EDVGTTPFSYKALRR

NID1

306

P14543
EYNDGRKTFPRARRT

MAP3K2

276

Q9Y2U5
SADAVSVYKRGEGRP

MYO10

1976

Q9HD67
PDTSRRYENKAGSFI

NCBP3

61

Q53F19
PEFTESEKRRINGTY

LCT

1661

P09848
VPYTSRRPKDSEREG

MPP2

406

Q14168
RRPKDSEREGQGYSF

MPP2

411

Q14168
RYPTVEKRARVFNGA

AP5M1

26

Q9H0R1
VSDSFREYSAPGVRR

PLA2G4B

701

P0C869
RYRKLRVFSGSAVPA

PNMA2

161

Q9UL42
IRKREGSDSYAITFR

PLCG2

671

P16885
GPAAYRQTDVRVTKF

ODF3

181

Q96PU9
DRPAVEKARTLYRSC

MMEL1

161

Q495T6
AKAISPEGEDRFYRR

ARHGAP32

1816

A7KAX9
GEASDPKYITDRRFR

GAL3ST4

411

Q96RP7
ADSVPGTYRKVVAAR

PCLAF

6

Q15004
EGTKPERRSFRAYAA

MORC2

231

Q9Y6X9
RRVRSKSDTPYLAEA

PHACTR1

61

Q9C0D0
RIVEKGFYTERDASR

CAMK1

106

Q14012
ADGYKVVFVRRSPLV

MON1A

301

Q86VX9
VSRSAGKAEIARAYR

DNAJC25

56

Q9H1X3
EACYFRRETTKRPSL

IL33

56

O95760
TYEFRSDSARGIRIP

CBX8

91

Q9HC52
GRRKRFPTDKAYFIA

FARP1

531

Q9Y4F1
RPRVRFDGVYISKTT

FBXO9

261

Q9UK97
EERKTDSYRYPRTGS

DPP9

296

Q86TI2
RGASVFIQTDKPVYR

CPAMD8

126

Q8IZJ3
LETRRADSFRYPKTG

DPP8

321

Q6V1X1
SRGRYAERDIVQFVP

CPNE9

481

Q8IYJ1
TERYGAVFSSREQPK

DDX12P

531

Q92771
VFEDSLGPYARVKRV

DEGS2

301

Q6QHC5
DPRVTRAKYFIRDEF

GNAS

331

P63092
RVGVVRYSDRPTTAF

COL22A1

76

Q8NFW1
EYRGRTTFVSKDISR

BTN2A1

91

Q7KYR7
PSVDGQKRYTFRVRS

IL2RG

211

P31785
YRFRPTSVGESRTLK

CEP192

2446

Q8TEP8
IATKEDPRSFYERGV

DYNC1H1

4626

Q14204
RPESFAIYKRTREDG

LAMC1

156

P11047
AEFYSRGRKQRRPSA

LINC01560

16

Q8TB33
PGRKYTFRVRAVTSE

IGFN1

711

Q86VF2
AFRFKDKERPRGYTS

IDE

421

P14735
EGRPETEYRKAQTFS

HEPACAM2

386

A8MVW5
PEYREEGAAVASRVR

FBN2

61

P35556
YVKSPAAERRSGAVA

FARP2

436

O94887
SPAVFVYKGGRERTE

BTN2A2

76

Q8WVV5
KSLYGFPESRKRREA

SCNN1G

126

P51170
YATSKDAREPVVGAR

CHID1

306

Q9BWS9
RGFFYTPKTRREAED

INS-IGF2

46

F8WCM5
KRFLRDGYRTSLEDP

PHKB

331

Q93100
FRRFYRGDSPTDSQK

SDHAF2

31

Q9NX18
EVVYEKANPSERRFG

MKRN1

286

Q9UHC7
AIKEQYTVRRFRGPS

NRK

351

Q7Z2Y5
EPRNGRVFKYFRVTE

PDILT

316

Q8N807
GTLKREPDNRRFSSY

PKP1

106

Q13835
AAYRADPLRVSSRDK

FUNDC2

21

Q9BWH2
RSEYRKRGFQEVVTP

TARS1

361

P26639
SPDTLRRVFEKYGRV

SRSF2

26

Q01130
GDVYIPRDRYTKESR

SRSF2

41

Q01130
PRDRYTKESRGFAFV

SRSF2

46

Q01130
RAFDSYERIKVPRVA

SEMA4F

256

O95754
RRAAAERPKYTFDFS

TOP2B

1361

Q02880
TFEQTKYLAGPERAR

NKX6-2

166

Q9C056
VGTPDFARRFRATYV

PIP4P2

211

Q8N4L2
YDTDAGPVFVKVNRR

FN3K

31

Q9H479
PFEYTGKDGRRVAIR

ARHGAP27

16

Q6ZUM4
KVSYKGSPAARRAFV

SMARCA4

831

P51532
EVGRRTTFRLFYPES

ST3GAL6

156

Q9Y274
CRRFFDRGYSPKDVA

SLFN11

796

Q7Z7L1
VLTRRFGKTYDAPSA

PTTG2

41

Q9NZH5
SPDSLRRVFEKYGRV

SRSF8

26

Q9BRL6
GRRRSFAERYDPSLK

ABCC12

16

Q96J65
DTRKFRSEPRSIFEY

SORBS2

201

O94875
PAYSKRGDIVFVDRA

SPTLC1

176

O15269
DFVRDKFTRRDGSVP

SLC25A12

411

O75746
RPAKDARASTYGVAV

CGN

41

Q9P2M7
PKRSGIARVTFDLYR

CIDEA

121

O60543
KAAAAELERRYPGTR

CHPF2

546

Q9P2E5
YPGRRVIEFSEDKVR

TJAP1

326

Q5JTD0
KGDVSSVRYRFETQP

XIRP2

1206

A4UGR9
KAFRYRPSFRTQERD

ZNF440

151

Q8IYI8
EAVLSADPRSVYRRK

TRMO

376

Q9BU70
PTEKFAVRKARRYSA

TTC39B

511

Q5VTQ0
QRRSVYGTAEFKEPT

MISP3

171

Q96FF7
RAYDTVRSSFKPGLE

SHANK3

846

Q9BYB0
SFTVQYKDRDGRPRA

TNXB

1401

P22105
IRPGKTSRDFDRYQE

PLCG1

81

P19174
RKSRPDEGVYVCVAR

ROBO1

136

Q9Y6N7
KGYRTRRLAADFSVP

CAD

1411

P27708
DYDTRASEPGKKRVR

YLPM1

2086

P49750
APAFRDYVAVARGSK

PRKDC

4071

P78527
RDKRSRLIEGYTGPF

ZNF862

171

O60290
DRSFGEKRYEPIQAT

TJP1

1411

Q07157
PDGSFRRQRKGYEEV

SNRNP200

431

O75643
IYRRVTSGVKPASFD

WNK1

431

Q9H4A3
RPESFAIYKRSRADG

LAMC3

141

Q9Y6N6
GFDIKDVARRYPEVT

EXD3

211

Q8N9H8
TRFTVPGLRTGKEYE

MYOM3

656

Q5VTT5